Profile: Zeus Scientific, Inc. is a global healthcare company that provides diagnostic products for the enhancement of patient care. We are an ISO 9001 certified company. We offer products like Athena, elisa & IFA. Our Athena Multi-Lyte® test system is a multiplexed, fluorescent, bead-based system designed to perform multiple assays. Our tissue fixative and wash solution is intended for transporting & processing fresh skin, kidney tissue, muscle & benign or malignant lymphoid tissue when performing immunohistochemical examinations & is intended for vitro diagnostic use.

The company was founded in 1976, has revenues of USD 10-25 Million, has ~60 employees and is ISO 9001 certified.

FDA Registration Number: 2242436

51 to 67 of 67 Products/Services (Click for related suppliers)  Page: 1 [2]

• Rheumatoid Factor (RF)

• Rheumatoid Factor Test System (FDA Code: DHR / 866.5775) A rheumatoid factor immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the rheumatoid factor (antibodies to immunoglobulins) in serum, other body fluids, and tissues. Measurement of rheumatoid factor may aid in the diagnosis of rheumatoid arthritis.

• Rubella Enzyme Linked Immunoabsorbent Assay (FDA Code: LFX / 866.3510) Rubella virus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to rubella virus in serum. The identification aids in the diagnosis of rubella (German measles) or confirmation of a person's immune status from past infections or immunizations and provides epidemiological information on German measles. Newborns infected in the uterus with rubella virus may be born with multiple congenital defects (rubella syndrome).

• Rubella IgG EIA Kit

• Rubella IgM EIA Kit

• Rubeola Enzyme Linked Immunoabsorbent Assay (FDA Code: LJB / 866.3520) Rubeola (measles) virus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to rubeola virus in serum. The identification aids in the diagnosis of measles and provides epidemiological information on the disease. Measles is an acute, highly infectious disease of the respiratory and reticuloendothelial tissues, particularly in children, characterized by a confluent and blotchy rash.

• Rubeola Fluorescent Antiserum (FDA Code: GRE / 866.3520)

• Thyroglobulin (FDA Code: DDC / 866.5870) A thyroid autoantibody immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the thyroid autoantibodies (antibodies produced against the body's own tissues). Measurement of thyroid autoantibodies may aid in the diagnosis of certain thyroid disorders, such as Hashimoto's disease (chronic lymphocytic thyroiditis), nontoxic goiter (enlargement of thyroid gland), Grave's disease (enlargement of the thyroid gland with protrusion of the eyeballs), and cancer of the thyroid.

• Thyroglobulin IgG EIA Kit

• Thyroid Autoantibody Test System (FDA Code: JZO / 866.5870)

• Toxoplasma Gondii Antibody Test

• Toxoplasma Gondii Enzyme Linked Immunoabsorbent Assay (FDA Code: LGD / 866.3780)

• Toxoplasma IgG EIA Kit

• Treponema Pallidum Antibody

• Varicella-Zoster Antibody Test

• Varicella-Zoster CF Antigen (FDA Code: GQW / 866.3900) Varicella-zoster virus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to varicella-zoster in serum. The identification aids in the diagnosis of diseases caused by varicella-zoster viruses and provides epidemiological information on these diseases. Varicella (chicken pox) is a mild, highly infectious disease, chiefly of children. Zoster (shingles) is the recurrent form of the disease, occurring in adults who were previously infected with varicella-zoster viruses. Zoster is the response (characterized by a rash) of the partially immune host to a reactivation of varicella viruses present in latent form in the patient's body.

• Varicella-Zoster Enzyme Linked Immunoabsorbent Assay (FDA Code: LFY / 866.3900)